Global Market Expansion Accelerates with Back-to-Back FDA and EC Authorizations Dong-A ST (CEO: Jeong Jae-hoon, KRX: 170900) proudly announces that its Stelara biosimilar, IMULDOSA (Project Name: ...
The recent revelation about the approval of self-replicating mRNA vaccines poses significant questions about public safety and governmental transparency. The European Committee for Medicinal Products ...